檢索結果 - Elizabeth Rich

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    A Role for Oxytocin in the Etiology and Treatment of Schizophrenia

    A Role for Oxytocin in the Etiology and Treatment of Schizophrenia 由 Megan Elizabeth Rich, Heather K. Caldwell

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Impairments in the Initiation of Maternal Behavior in Oxytocin Receptor Knockout Mice

    Impairments in the Initiation of Maternal Behavior in Oxytocin Receptor Knockout Mice 由 Megan Elizabeth Rich, Emily J. deCárdenas, Heon‐Jin Lee, Heather K. Caldwell

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    BK Virus Infection Is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell Transplants

    BK Virus Infection Is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell Transplants 由 Peter H. O’Donnell, Kate Swanson, Michelle A. Josephson, Andrew Artz, Sandeep Parsad, Charulata Ramaprasad, Kenneth Pursell, Elizabeth Rich, Wendy Stock, Koen van Besien

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation

    Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation 由 Andrew Artz, Amittha Wickrema, Shira Dinner, Lucy A. Godley, Masha Kocherginsky, Olatoyosi Odenike, Elizabeth Rich, Wendy Stock, Jodie Ulaszek, Richard A. Larson, Koen van Besien

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

    Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Pa... 由 Jordi Esteve, Rik Schots, Teresa Bernal, Je‐Hwan Lee, Eunice S. Wang, Shira Dinner, Mark D. Minden, Olga Salamero, Jorge Sierra, Goichi Yoshimoto, Kamel Laribi, Janusz Hałka, Pau Montesinos, Shufang Liu, Elizabeth Rich, Erkut Bahceci

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation

    Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation 由 Andrew Artz, Daniel A. Pollyea, Masha Kocherginsky, Wendy Stock, Elizabeth Rich, Olatoyosi Odenike, Todd M. Zimmerman, Sonali M. Smith, Lucy A. Godley, Michael J. Thirman, Christopher K. Daugherty, Martine Extermann, Richard A. Larson, Koen van Besien

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

    Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions 由 Hongtao Liu, Elizabeth Rich, Lucy A. Godley, Olatoyosi Odenike, Loren Joseph, Susana R. Marino, Justin Kline, Vu Nguyen, John M. Cunningham, Richard A. Larson, Paula del Cerro, Linda Schroeder, Lisa Pape, Wendy Stock, Amittha Wickrema, Andrew Artz, Koen van Besien

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML

    Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML 由 Keith W. Pratz, Mohamad Cherry, Jessica K. Altman, Brenda Cooper, Nikolai A. Podoltsev, José C. Cruz, Tara L. Lin, Gary J. Schiller, Joseph G. Jurcic, Adam Asch, Ruishan Wu, Jason E. Hill, Stanley C. Gill, Angela James, Elizabeth Rich, Nahla Hasabou, Alexander E. Perl, Mark J. Levis

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy

    Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy 由 Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je‐Hwan Lee, Michael Heuser, Tomoki Naoe, Wen‐Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Carlo Gambacorti‐Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Rich, Ramón V. Tiu

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: